Precision Cancer Medicine : Impact Factor & More
eISSN: 2617-2216
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Precision Cancer Medicine
Precision Cancer Medicine Journal Specifications
Indexed in the following public directories
Scopus 
SJR
| Overview | |
| Publisher | AME Publishing Company |
Planning to publish in Precision Cancer Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Precision Cancer Medicine
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
- 1 May 2025
- Precision Cancer Medicine
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
- 1 Sep 2024
- Precision Cancer Medicine
Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a case report
- 1 Sep 2024
- Precision Cancer Medicine
Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model
- 1 Sep 2024
- Precision Cancer Medicine
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
- 1 Sep 2024
- Precision Cancer Medicine
NTRK1/2/3: biology, detection and therapy
- 1 Sep 2024
- Precision Cancer Medicine
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
- 1 May 2025
- Precision Cancer Medicine
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
- 1 Sep 2024
- Precision Cancer Medicine
Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a case report
- 1 Sep 2024
- Precision Cancer Medicine
Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model
- 1 Sep 2024
- Precision Cancer Medicine
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
- 1 Sep 2024
- Precision Cancer Medicine
NTRK1/2/3: biology, detection and therapy
- 1 Sep 2024
- Precision Cancer Medicine
FAQs on Precision Cancer Medicine
How many articles did Precision Cancer Medicine publish last year? 
Who is the publisher of Precision Cancer Medicine?
